Attached files
| file | filename |
|---|---|
| EX-10.6.1 - EX-10.6.1 - InMed Pharmaceuticals Inc. | d904092dex1061.htm |
| EX-10.4.4 - EX-10.4.4 - InMed Pharmaceuticals Inc. | d904092dex1044.htm |
| EX-1.1 - EX-1.1 - InMed Pharmaceuticals Inc. | d904092dex11.htm |
| S-1/A - S-1/A - InMed Pharmaceuticals Inc. | d904092ds1a.htm |
Exhibit 23.1
KPMG LLP
PO Box 10426 777 Dunsmuir Street
Vancouver BC V7Y 1K3
Canada
Telephone (604) 691-3000
Fax (604) 691-3031
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
InMed Pharmaceuticals Inc.:
We, KPMG LLP, consent to the use of our report dated March 27, 2020, on the consolidated financial statements of InMed Pharmaceuticals Inc. and subsidiaries, which comprise the consolidated balance sheets as of June 30, 2019 and 2018, the related consolidated statements of operations and comprehensive loss, shareholders’ equity, and cash flows for each of the years in the two-year period ended June 30, 2019, and the related notes, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Chartered Professional Accountants
Vancouver, Canada
July 6, 2020
KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG network of
independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a
Swiss entity. KPMG Canada provides services to KPMG LLP.